Form 483

FDA stop sign
MedTech

FDA flags review of Telix's radiodiagnostic for kidney cancer

The FDA has asked Telix for more information about the manufacturing of its novel PET agent for clear-cell renal cell carcinoma.
Conor Hale Aug 28, 2025 11:20am
FDA

Dexcom receives FDA warning letter over manufacturing issues

Mar 10, 2025 11:53am